Showing results (181-190 of 273) with videos related to
Sort By:
Pageof 28
HIV Medicine|July 8, 2015
The influence of patient beliefs and treatment satisfaction on the discontinuation of current first-line antiretroviral regimensJ L Casado, A Marín, V Romero, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvementC Visco, L J Medeiros, D Jones, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphomaF Cabanillas, J Rodriguez-Diaz Pavón, F B Hagemeister, et al.Journal of Medical Primatology|January 1, 1994
Temperature-metabolism relations in the cotton-top tamarin (Saguinus oedipus) model for ulcerative colitisM J Stonerook, H S Weiss, M A Rodriguez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphomaA Younes, A Sarris, A Melnyk, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 14, 1998
Is the femoral cannulation for minimally invasive aortic valve replacement necessary?J Cuenca, M A Rodriguez-Delgadillo, J V Valle, et al.Cancer|April 13, 2000
p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinomaM S Kahlenberg, D L Stoler, M A Rodriguez-Bigas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphomaP McLaughlin, F B Hagemeister, F Swan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2009
Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatmentG S Falchook, F Vega, N H Dang, et al.Blood|May 26, 1999
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's diseaseJ Rodriguez, M A Rodriguez, L Fayad, et al.Pageof 28